Pharmalicensing.com Send to a colleague
June 2013
 
Pharmalicensing recommends...

Top 5 Recommendations

 
Small molecule platform capable of enhancing osteogenic differentiation of stem cells for the treatment of bone disorders  
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them more

 

Novel, ready-to-market, next generation of pain relief patch product sought for topical analgesic leader 
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio more
 
 
Safe, versatile, and persistent polymeric antimicrobial product additive suitable for application in hospitals and healthcare environments 
Polymeric antimicrobial effective against 99.9% of Gram + and Gram – bacteria. Suitable for a range of applications including cleaning sprays, sanitizers, textiles, plastics, resins, rubber, paints, coatings, and waxes.  more
 
 

US based animal health contract manufacturer producing pharmaceuticals, nutraceuticals and medicated feeds seeking customers globally for its services
Our client is a leading long standing contract manufacturer with expertise in producing pharmaceuticals, nutraceuticals and medicated feed products for the animal health industry more 
 
 
Modified hydroxyapatite (HA) products, biomaterials and applications for the improvement of bone/tooth repair products and implant anchoring
Scientists have developed novel biomaterials comprising of modified hydroxyapatite (HA) which can be used to improve bone, dental and oral health products as well as implant anchoring into the body more
 
       

Out-Licensing

 
Novel analgesic compound with wound healing/anaesthetic properties suitable for a wide range of dermatological and dental applications
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market more 

  

Nicotine replacement therapy product available to out-license or co-develop 
This transbuccal (tiny spray on the inside of the cheek) nicotine replacement therapy (NRT) is delivered rapidly into the bloodstream where it provides immediate relief from nicotine cravings more
 
 
 
Animal Health: Omega-3 fatty acids to treat joint care, asthma and dermatitis in animals 
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals more  

 

An OTC benign mucosal protective throat spray; capable of relieving chronic sore throat, cough, hoarseness, and post-nasal drip; the symptoms of acid reflux in addition to environmental and other throat conditions
Powder spray providing a benign mucosal barrier over the entire throat, combating the reflux related symptoms of stomach acid and enzymes in the throat, utilizing a purified, organic, safe and effective natural compound more

 

OTC safe and effective ear wax remover
Our client has developed a solution to successfully prevent unwanted earwax build-up more

 

Topical OTC (Europe) and Rx (United States) Diclofenac pain relief product 
Using a unique resin-based topical delivery system, this product provides more effective local pain relief and longer periods of sustained relief compared to existing products more  

 

 
“Plant Milking” Technology capable of producing high value active cosmetic compounds from the roots of rare, protected, slow to grow plant species
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved. It is currently used by a top 5 global cosmetics company. more
 
 
Adipose tissue derived stem cells available for development to treat musculoskeletal, metabolic, ophthalmic or cardiovascular related disorders 
Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and anti-ageing more  
    
 
Effective Anti-inflammatory Omega-3 fatty acids sourced from green lipped mussels 
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients more
 
 
Clinical candidate GABA-based compounds based for neuropathic pain 
Our Eastern based client has identified a group of compounds that are effective in the treatment of neuropathic chronic pain and have no CNS-related side effects more   
 
 
Technology to source new APIs from plant species 
The plant milking technology is capable of producing high value active pharmaceutical compounds more
 
 
Anti-microbial Monocaprin emulsion, available for use as a cleaning solvent in the preparation and protection of food, detergents and cosmetics
Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics more
 
 
Tension free vaginal support (TVS) medical device indicated for stress incontinence in women  
Women’s health specialists have created a non invasive class IIa medical device for the successful control of stress related incontinence more
 
             

In-licensing

 
Seeking innovative oncology, immunology or orphan disease focused prescription based hospital products required for the Portuguese market 
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases more
 
 
Oncology or neurology Phase I/Phase II products and/or technologies sought for in-licensing or acquisition 
Our leading apoptosis focused clinical stage drug development company seeks to in-license or acquire early stage clinical projects or technologies at phase I or II in the areas of either oncology or neurology more

 

Global Animal Health Company seeks new veterinary external anti-parasitic compounds to treat companion (dogs and cats) and food producing (pigs, cattle, chickens) animals 
Our global animal health clients seek new anti-parasitic compounds to treat external parasites affecting companion animals (dogs, cats etc.) and food producing animals (e.g. pigs, cattle, chicken) more
 
  
 
Inside...
  • Read further details about each of these opportunities by visiting our company profile page . Each listing is categorized by both therapy and industry sector. 

Find out more!

For further detailed information on each of these opportunities, including who to contact, visit our company profile page

Each partnering opportunity includes the following information:

  • Contact details
  • Full opportunity description
  • Stage of development
  • Type of partnering relationship sought
 

IP Technology Exchange, Inc
2109 East Palm Ave.
Tampa, Fl 33605
Email:  info@pharmalicensing.com


IP Technology Exchange, Inc
If you no longer wish to receive this newsletter please unsubscribe